The Bi2Se3 HNC-s-s-HA/GA could target CD44-overexpressing cancer cells, achieve GSH-sensitive GA release, and inhibit HSP90, and could hence accomplish more efficient low-temperature PTT under mild NIR laser irradiation. The gene discussed is CD44; the disease is cancer.